Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.63+5.52%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · RXRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 54.9 | 74.7 | 58.8 | 44.6 | 39.8 | 10.2 | 4.0 |
| Cost of Revenues | 52.9 | 71.0 | 45.2 | 42.6 | 48.3 | 0.0 | 0.0 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 394.5 | 475.3 | 314.4 | 241.2 | 155.7 | 135.3 | 63.3 |
| Operating Income | (544.0) | (648.1) | (479.0) | (350.1) | (245.7) | (182.8) | (84.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 1.8 | 1.6 | 0.1 | 0.1 | 3.0 | 1.4 |
| Interest & Investment Income | 23.1 | 22.8 | 15.8 | 19.1 | 6.3 | 0.1 | 0.3 |
| Net Interest Expenses | — | — | — | (19.0) | (6.2) | 2.9 | 1.0 |
| Other Non-Operating Income / Expenses | 20.5 | 3.2 | 14.2 | 17.9 | 6.3 | (3.7) | (2.4) |
| Asset Writedown | — | — | — | — | — | 0.0 | 0.9 |
| EBT, Incl. Unusual Items | (523.5) | (644.9) | (464.8) | (332.1) | (239.5) | (186.5) | — |
| Income Tax Expense | (4.6) | (0.1) | (1.1) | (4.1) | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (518.9) | (644.8) | (463.7) | (328.1) | (239.5) | (186.5) | (87.0) |
| Per Share | |||||||
| Basic EPS | (0.97) | (1.44) | (1.69) | (1.58) | (1.36) | (1.49) | (3.99) |
| Diluted EPS | (0.97) | (1.44) | (1.69) | (1.58) | (1.36) | (1.49) | (3.99) |
| Revenue per Share | 0.10 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 532.5 | 447.4 | 274.2 | 207.9 | 175.5 | 125.3 | 21.8 |
| Diluted Weighted Avg Shares | 532.5 | 447.4 | 274.2 | 207.9 | 175.5 | 125.3 | 21.8 |
| Supplemental | |||||||
| EBITDA | — | (564.4) | (442.5) | (325.7) | (234.0) | (174.4) | (80.7) |
| EBIT | (544.0) | (648.1) | (479.0) | (350.1) | (245.7) | (182.8) | (84.6) |
| Effective Tax Rate | 0.9% | — | — | 1.2% | 0.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.